-
Taxonomy & unit
-
us-gaap: EUR and USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Amphastar Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate for Q1 2014.
- Amphastar Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending April 30, 2014 was €3.2M.
Deferred Tax Assets, Valuation Allowance, Quarterly (EUR)